Same Indication

Pembrolizumab vs Pentagastrin

Pembrolizumab vs Pentagastrin: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Pentagastrin.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days.

Chemical Properties

Type: Pembrolizumab — Antibody; Pentagastrin — Small molecule.